Concepedia
Statistics
Publications
9
Citations
327
H-Index
Active since
2003
Affiliations
Pfizer (United States)(Current)
Pfizer (United Kingdom)
Alan MacInnes is an author at Pfizer (United States) specializing in pharmacology, pharmacy, and enzyme inhibition.
Publications per year
2003–2011
The Antianginal Agent Trimetazidine Does Not Exert Its Functional Benefit via Inhibition of Mitochondrial Long-Chain 3-Ketoacyl Coenzyme A Thiolase
Alan MacInnes, David Fairman, Peter Binding et al. · Circulation Research · 2003 · 124 citations · Full text
Medicine, Biochemistry, Pharmacology +16
Maraviroc Can Improve Lipid Profiles in Dyslipidemic Patients with HIV: Results from the MERIT Trial
Alan MacInnes, Adriano Lazzarin, Giovanni Di Perri et al. · HIV Clinical Trials · 2011 · 50 citations
Pharmacy, Pharmacology, Pharmacotherapy +17
Genetic Association of the CCR5 Region With Lipid Levels in At-Risk Cardiovascular Patients
Craig Hyde, Alan MacInnes, Frances Sanders et al. · Circulation Cardiovascular Genetics · 2010 · 31 citations · Full text
Medicine, Genetics, Molecular Genetics +15
The Experimental Type 2 Diabetes Therapy Glycogen Phosphorylase Inhibition Can Impair Aerobic Muscle Function During Prolonged Contraction
David Baker, Paul L. Greenhaff, Alan MacInnes et al. · Diabetes · 2006 · 29 citations · Full text
Life Sciences, Biochemistry, Physiology +15
Identification, synthesis and SAR of amino substituted pyrido[3,2b]pyrazinones as potent and selective PDE5 inhibitors
Dafydd R. Owen, John K. Walker, E. Jon Jacobsen et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 23 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +12
1–5 of 9